Thomas Brodowicz

817 citations
32 papers · 582 · h-index 15

Impact in

Papers in

    • Sarcoma Diagnosis and Treatment 10
    • Renal cell carcinoma treatment 2
    • Colorectal Cancer Treatments and Studies 4
    • Vascular Tumors and Angiosarcomas 4
    • Cancer Treatment and Pharmacology 2

Thomas Brodowicz

32 papers receiving 574 citations

Peers

Thomas Brodowicz
Comparison fields: 5 of 71
  • Oncology 183
  • Pulmonary and Respiratory Medicine 205
  • Rheumatology 95
  • Pathology and Forensic Medicine 78
  • Gastroenterology 18
Replace Keisuke Hanioka with:
Keisuke Hanioka Japan
Jorge Torres‐Mora United States
Marta Braschi‐Amirfarzan United States
Fang Li China
Javier Lavernia Spain
Myrella Vlenterie Netherlands
Jorge Dotto United States
Thomas Zaramboukas Greece
J.‐F. Goussot France
Brian P. Whooley United States
Thomas Brodowicz relative to Keisuke Hanioka Japan Keisuke Hanioka's profile →
Citations per field
00.5×3.1×
Keisuke Hanioka · 1×
Citations per year

Countries citing papers authored by Thomas Brodowicz

Since Specialization
Citations

This map shows the geographic impact of Thomas Brodowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Brodowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Brodowicz more than expected).

Fields of papers citing papers by Thomas Brodowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Brodowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Brodowicz. The network helps show where Thomas Brodowicz may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Brodowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Brodowicz Line = papers co-authored together Thomas Brodowicz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202060
2 199958
3 200156
4 200038
5 199729
6 201429
7 201928
8
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.
200425
9 200121
10 201520
11 200219
12 200019
13
Recurrent malignant Triton tumour: first report on a long time survivor.
200319
14 201717
15 200115
16 201314
17 201613
18 200813
19 200011
20 201510

About Thomas Brodowicz

Thomas Brodowicz is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cardiology and Cardiovascular Medicine, Rheumatology and Pathology and Forensic Medicine, having authored 32 papers that have together received 582 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (10 papers), Cardiac tumors and thrombi (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Vascular Tumors and Angiosarcomas (4 papers), Renal cell carcinoma treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Bone Tumor Diagnosis and Treatments (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (183 citations), Pulmonary and Respiratory Medicine (205 citations), Rheumatology (95 citations), Pathology and Forensic Medicine (78 citations) and Gastroenterology (18 citations). Thomas Brodowicz has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Christoph Zielinski, Wolfgang J. Köstler, Michael Krainer, Christoph Wiltschke, Alexandra C. Budinsky, Michael Hejna, Michael Marberger, Andreas Leithner, Joanna Szkandera and Sandra Tomek. Their work appears in journals such as Anti-Cancer Drugs, Journal of Clinical Oncology, Cancer Immunology Immunotherapy, Modern Pathology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact